Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Isotretinoin and Cutaneous Helper T-Cell Lymphoma (Mycosis Fungoides)
John F. Kessler
, Stephen E. Jones
, Norman Levine
, Peter J. Lynch
, Ann Rohman Booth
, Frank L. Meyskens
Dermatology
Research output
:
Contribution to journal
›
Article
›
peer-review
122
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Isotretinoin and Cutaneous Helper T-Cell Lymphoma (Mycosis Fungoides)'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Mycosis Fungoides
100%
T Helper Cells
100%
T-cell Lymphoma
100%
Isotretinoin
100%
Clinical Trials
25%
Phase II Trial
25%
Pathologic
25%
Retinoids
25%
Duration of Response
25%
Antiproliferative Activity
25%
Clinical Response
25%
Clinical Benefit
25%
Dose Reduction
25%
Response Rate
25%
Median Time
25%
Laboratory Trials
25%
Clinical Improvement
25%
Time Response
25%
Toxic Reaction
25%
Antineoplastic Agents
25%
Mucous Membrane
25%
Clinical Complete Response
25%
Skin Membrane
25%
Medicine and Dentistry
Mycosis fungoides
100%
T-Cell Lymphoma
100%
Isotretinoin
100%
Clinical Trial
25%
Retinoid
25%
Phase II Trials
25%
Antineoplastic Activity
25%
Antiproliferative Activity
25%
Drug Dose Reduction
25%
Diseases
25%
Nursing and Health Professions
T Cell Lymphoma
100%
Isotretinoin
100%
Mycosis fungoides
100%
Treatment Response Time
25%
Drug Dose Reduction
25%
Antineoplastic Activity
25%
Retinoid
25%
Diseases
25%
Pharmacology, Toxicology and Pharmaceutical Science
T Cell Lymphoma
100%
Isotretinoin
100%
Mycosis fungoides
100%
Phase II Trials
25%
Clinical Trial
25%
Retinoid
25%
Diseases
25%